[go: up one dir, main page]

GB1540049A - 9,11-bridged prostaglandins - Google Patents

9,11-bridged prostaglandins

Info

Publication number
GB1540049A
GB1540049A GB30846/77A GB3084677A GB1540049A GB 1540049 A GB1540049 A GB 1540049A GB 30846/77 A GB30846/77 A GB 30846/77A GB 3084677 A GB3084677 A GB 3084677A GB 1540049 A GB1540049 A GB 1540049A
Authority
GB
United Kingdom
Prior art keywords
compounds
sulphonating
prepared
prostaglandins
bridged
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB30846/77A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/810,811 external-priority patent/US4112224A/en
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of GB1540049A publication Critical patent/GB1540049A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0016—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing only hydroxy, etherified or esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0041—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/04—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Novel prostaglandin analogues of the formula <IMAGE> in which the substituents are defined in Claim 1, are prepared. These compounds are obtained by alkyl-sulphonating, aralkyl-sulphonating or aryl-sulphonating a corresponding 9,11-dihydroxy compound at carbon atoms 9 and 11. In a second reaction step, the resulting compound is then reacted with hydrazine. In addition, corresponding azo compounds are prepared from the compounds CXIII by oxidation, or corresponding monoalkyl, monoacyl, dialkyl or diacyl compounds by alkylation or acylation. The prostaglandin analogues which are obtained can be used for the same pharmacological purposes as the natural prostaglandins.
GB30846/77A 1976-08-16 1977-07-22 9,11-bridged prostaglandins Expired GB1540049A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71439076A 1976-08-16 1976-08-16
US05/810,811 US4112224A (en) 1976-08-16 1977-06-30 Biheterocyclic-9,11-trideoxy-PGF compounds

Publications (1)

Publication Number Publication Date
GB1540049A true GB1540049A (en) 1979-02-07

Family

ID=27109143

Family Applications (1)

Application Number Title Priority Date Filing Date
GB30846/77A Expired GB1540049A (en) 1976-08-16 1977-07-22 9,11-bridged prostaglandins

Country Status (8)

Country Link
JP (1) JPS5323967A (en)
AU (1) AU505149B2 (en)
CH (2) CH632252A5 (en)
DE (1) DE2736782A1 (en)
FR (1) FR2362130A1 (en)
GB (1) GB1540049A (en)
HU (1) HU180103B (en)
NL (1) NL7708963A (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4100192A (en) * 1977-04-18 1978-07-11 The Upjohn Company Inter-phenylene-PG amides
JPS5925443A (en) * 1982-08-02 1984-02-09 Mitsubishi Electric Corp Calibration method of radar receiver
US5213388A (en) * 1991-09-30 1993-05-25 Baker Franklin W Anti-theft vehicle seat apparatus

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3950363A (en) * 1975-03-10 1976-04-13 The Upjohn Company Prostaglandin cyclic ethers

Also Published As

Publication number Publication date
AU505149B2 (en) 1979-11-08
HU180103B (en) 1983-01-28
NL7708963A (en) 1978-02-20
FR2362130A1 (en) 1978-03-17
CH632252A5 (en) 1982-09-30
JPS5323967A (en) 1978-03-06
DE2736782A1 (en) 1978-02-23
AU2729277A (en) 1979-02-01
FR2362130B1 (en) 1984-12-21
JPS6148504B2 (en) 1986-10-24
CH633543A5 (en) 1982-12-15

Similar Documents

Publication Publication Date Title
ES477695A1 (en) Derivatives of dehydrocyclicimino acids
SE8401135D0 (en) PROCEDURE FOR PRODUCING ISO CYCLOSPORIN D
KR850004757A (en) Preparation of substituted trans-1,2-diaminocyclohexyl amide compound
ES481220A1 (en) Novel Aminothiazoles
ES8101536A1 (en) PROCEDURE FOR PREPARING NEW DERIVATIVES OF PLEUROMUTI-LIN
JPS5297950A (en) Chalconeether derivatives
ES482010A1 (en) Heterocyclic compound
ES470745A1 (en) A PROCEDURE FOR PREPARING DERIVATIVES OF 6,6&#39;-OXIBIS-PYRONE HALO-SUBSTITUTE
GB1540049A (en) 9,11-bridged prostaglandins
GB1554048A (en) Prostacyclin derivatives
IE791781L (en) 4, 5-methano-bufadienolide rhamnosides
SE7714656L (en) SULFAMOYLBENZOIC ACIDS
ES434405A1 (en) Procedure for the preparation of imidazole derivatives. (Machine-translation by Google Translate, not legally binding)
ES471267A1 (en) Lower alkyl 2-tri-(lower)alkylsilylacetylene-N-carbethoxyglycinates and process for using same
ES520136A0 (en) A PROCEDURE FOR THE PREPARATION OF A DERIVATIVE OF FURILOXAZOLYL-CETICAL ACID
CH614932A5 (en) Process for the preparation of new terpenoaromatic amidines
JPS5265299A (en) Synthesis of 2-substituted-thioadenosine-n-oxides
ES464547A1 (en) Fungicidal 1-cycloalkylcarbonyl-3-(3,5-dihalophenyl)imidazolidine-2,4-diones
ES459954A1 (en) Derivatives of cyclopropane
ES459930A1 (en) Esters of 5-methyl-10,11-dihydroprostaglandin-A1
GB1522537A (en) 2,4-diamino-5-benzylpyrimidines
SE8302084D0 (en) NEW BENZIMIDAZOLE DERIVATIVES
GB1500039A (en) Alkenylxanthines and their conversion to hydroxyalkylxanthines
JPS5293730A (en) Thioethers
GB2004865A (en) Methyl-2-picolymercaptan and derivatives thereof which are useful as flavouring agents

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee